"The Neurobiology Program is committed to developing new diagnostic and therapeutic approaches for neurodegenerative diseases such as Alzheimer's disease and stroke, based on understanding of their development and progression from molecules to behavior.Our hope is that our discoveries will one day reduce disability and improve the quality of life of those affected by brain diseases."

Dr. Danica Stanimirovic,
Research Director, Neurobiology Program

The Neurobiology Program carries out fundamental and applied research in neuronal and non-neuronal cell function in relation to neurodegenerative diseases. This is achieved by combining a spectrum of models, ranging from cell to patient, and a variety of techniques spanning electrophysiology, genomics, proteomics, neuroglycobiology and molecular imaging.

The Program comprises a team of more than 100 scientific staff in six distinct groups: Cerebrovascular Research, Molecular Neurodegeneration, Glycosyltransferases and Neuroglycomics, Synaptic Therapies and Medical Devices, Proteomics, Neurogenesis and Brain Repair

More information about each group is listed below under Related Information.